1.29
price down icon8.51%   -0.12
 
loading
Stereotaxis Inc stock is traded at $1.29, with a volume of 1.30M. It is down -8.51% in the last 24 hours and down -20.86% over the past month. Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$1.41
Open:
$1.41
24h Volume:
1.30M
Relative Volume:
1.96
Market Cap:
$128.52M
Revenue:
$31.20M
Net Income/Loss:
$-21.68M
P/E Ratio:
-5.2826
EPS:
-0.2442
Net Cash Flow:
$-15.52M
1W Performance:
-16.77%
1M Performance:
-20.86%
6M Performance:
-51.69%
1Y Performance:
-42.41%
1-Day Range:
Value
$1.28
$1.4188
1-Week Range:
Value
$1.28
$1.63
52-Week Range:
Value
$1.28
$3.59

Stereotaxis Inc Stock (STXS) Company Profile

Name
Name
Stereotaxis Inc
Name
Phone
314-678-6100
Name
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Name
Employee
118
Name
Twitter
@stereotaxis
Name
Next Earnings Date
2026-08-11
Name
Latest SEC Filings
Name
STXS's Discussions on Twitter

Compare STXS vs ISRG, BDX, ALC, MDLN, RMD

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
STXS icon
STXS
Stereotaxis Inc
1.29 128.52M 31.20M -21.68M -15.52M -0.2442
ISRG icon
ISRG
Intuitive Surgical Inc
337.50 120.92B 11.03B 3.16B 3.22B 8.7251
BDX icon
BDX
Becton Dickinson Co
156.36 43.08B 21.37B 1.41B 3.07B 3.9437
ALC icon
ALC
Alcon Inc
67.91 33.12B 10.63B 819.00M 1.59B 1.6577
MDLN icon
MDLN
Medline Inc
38.75 32.77B 29.14B 1.07B 1.05B 1.1956
RMD icon
RMD
Resmed Inc
195.27 28.33B 5.54B 1.52B 1.74B 10.37

Stereotaxis Inc Stock (STXS) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-16-25 Initiated Citizens JMP Mkt Outperform
Jan-10-24 Initiated ROTH MKM Buy
Jul-12-22 Initiated Aegis Capital Buy
Jun-23-22 Initiated B. Riley Securities Buy
Jan-05-22 Initiated Craig Hallum Buy
Jan-05-22 Initiated Loop Capital Buy
May-26-21 Initiated Piper Sandler Overweight
Sep-08-20 Initiated Northland Capital Outperform
Apr-09-20 Initiated Cowen Outperform
Apr-07-20 Initiated Lake Street Buy
View All

Stereotaxis Inc Stock (STXS) Latest News

pulisher
Jul 22, 2026

Stereotaxis, Inc. (STXS) stock price, news, quote and history - Yahoo Finance UK

Jul 22, 2026
pulisher
Jul 21, 2026

Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026 - The Manila Times

Jul 21, 2026
pulisher
Jul 21, 2026

Stereotaxis to Discuss Robotic Intervention Results on Aug. 11 - Stock Titan

Jul 21, 2026
pulisher
Jul 20, 2026

Stereotaxis, Inc. opens new robotic EP laboratory in Hungary - Traders Union

Jul 20, 2026
pulisher
Jul 20, 2026

University of Szeged Pioneers First Robotic Cardiology Program in Hungary - GlobeNewswire

Jul 20, 2026
pulisher
Jul 20, 2026

University of Szeged Treats First Patients With Genesis System - Stock Titan

Jul 20, 2026
pulisher
Jul 20, 2026

Stereotaxis (STXS) Could Be 56% Undervalued After Shelf Registration Filings - Yahoo Finance

Jul 20, 2026
pulisher
Jul 19, 2026

STXS Slides As Stereotaxis Clears Massive Secondary Share Block - timothysykes.com

Jul 19, 2026
pulisher
Jul 16, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Jul 16, 2026
pulisher
Jul 16, 2026

Stereotaxis Faces Integration, Financial, and Regulatory Challenges Following Robocath Acquisition - Minichart

Jul 16, 2026
pulisher
Jul 16, 2026

Stereotaxis completes acquisition of Robocath; issues 6.27M shares, up to $25M earnout possible - TradingView

Jul 16, 2026
pulisher
Jul 16, 2026

Stereotaxis (NYSE American: STXS) flags Robocath earnouts and 19.9% dilution - Stock Titan

Jul 16, 2026
pulisher
Jul 15, 2026

Stereotaxis Files Resale Registration for Up to 108.9 Million Shares - Moomoo

Jul 15, 2026
pulisher
Jul 15, 2026

Form S-3 Stereotaxis Inc For: 15 July By Investing.com - Investing.com Nigeria

Jul 15, 2026
pulisher
Jul 10, 2026

Stereotaxis Finalizes Robocath Acquisition - dicardiology.com

Jul 10, 2026
pulisher
Jul 10, 2026

ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? - TradingView

Jul 10, 2026
pulisher
Jul 09, 2026

Stereotaxis closes Robocath takeover - MedTech Dive

Jul 09, 2026
pulisher
Jul 09, 2026

Stereotaxis completes acquisition of Robocath By Investing.com - Investing.com India

Jul 09, 2026
pulisher
Jul 09, 2026

Stereotaxis, Inc. completes Robocath acquisition to accelerate endovascular robotics expansion - Traders Union

Jul 09, 2026
pulisher
Jul 09, 2026

Stereotaxis Closes $45M Deal for Robocath - Medical Product Outsourcing

Jul 09, 2026
pulisher
Jul 09, 2026

Stereotaxis completes acquisition of Robocath - Investing.com

Jul 09, 2026
pulisher
Jul 09, 2026

Robocath deal adds stock, warrants and earnouts at Stereotaxis (STXS) - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

Stereotaxis Completes Acquisition of Robocath - GlobeNewswire

Jul 09, 2026
pulisher
Jul 09, 2026

Stereotaxis folds Robocath into its surgical robotics platform - Stock Titan

Jul 09, 2026
pulisher
Jul 08, 2026

Enterprise value to revenue forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView

Jul 08, 2026
pulisher
Jul 07, 2026

Price to sales forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView

Jul 07, 2026
pulisher
Jul 07, 2026

Enterprise value to EBITDA forward of Stereotaxis, Inc. – DUS:RJR1 - TradingView

Jul 07, 2026
pulisher
Jul 06, 2026

Stereotaxis, Inc. completed the acquisition of Robocath SAS. - marketscreener.com

Jul 06, 2026
pulisher
Jul 06, 2026

Enterprise value to EBITDA forward of Stereotaxis, Inc. – LS:A1J09L - TradingView

Jul 06, 2026
pulisher
Jul 04, 2026

Price to book forward of Stereotaxis, Inc. – AMEX:STXS - TradingView

Jul 04, 2026
pulisher
Jul 01, 2026

Director Ross B. Levin receives 43,103 Stereotaxis (STXS) restricted share units - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

Director at Stereotaxis (STXS) receives 43,103-share equity grant - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

Stereotaxis (STXS) director awarded 43,103 restricted share units, holding 1,035,560 shares - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

Robotics redefine electrophysiology, Stereotaxis, Inc. explores in latest podcast - Traders Union

Jul 01, 2026
pulisher
Jul 01, 2026

STXS Q1 2026 Earnings: EPS Misses Estimates as Stock SlipsWeak Earnings Momentum - dars.gov.et

Jul 01, 2026
pulisher
Jun 29, 2026

Citizens Sees Compelling Razor/Razor Blade Ecosystem As A Driver Of Sustainable Growth For Stereotaxis (STXS) - Yahoo Finance

Jun 29, 2026
pulisher
Jun 29, 2026

Stereotaxis Inc. (STXS) Holds Near Support Amidst Low VolatilityMomentum Stock Picks - dars.gov.et

Jun 29, 2026
pulisher
Jun 29, 2026

Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Jun 29, 2026
pulisher
Jun 29, 2026

Price to earnings forward of Stereotaxis, Inc. – AMEX:STXS - TradingView

Jun 29, 2026
pulisher
Jun 28, 2026

Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 3000 Value Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 28, 2026

STXSStereotaxis Inc Options - Finviz

Jun 28, 2026
pulisher
Jun 28, 2026

Stereotaxis, Inc.(NYSEAM: STXS) dropped from Russell 2500 Value Benchmark - marketscreener.com

Jun 28, 2026
pulisher
Jun 27, 2026

Stereotaxis, Inc. Hits New 52-Week Low at $1.60 Amid Decline - MarketsMojo

Jun 27, 2026
pulisher
Jun 27, 2026

Stereotaxis (STXS) Gains 3.7% as Stock Hovers Near Key ResistanceSymmetrical Triangle - dars.gov.et

Jun 27, 2026
pulisher
Jun 27, 2026

8 Most Promising Robotics Stocks Now - Insider Monkey

Jun 27, 2026
pulisher
Jun 26, 2026

Enterprise value to EBIT forward of Stereotaxis, Inc. – AMEX:STXS - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to revenue forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Price to sales forward of Stereotaxis, Inc. – TRADEGATE:RJR1 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Stereotaxis, Inc. Actuals & Estimates (AMEX:STXS) - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

STXS Q1 2026 Earnings: EPS Misses Estimates as Company Navigates Strategic TransitionQuarterly Financial Update - dars.gov.et

Jun 25, 2026

Stereotaxis Inc Stock (STXS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
BAX BAX
$22.40
price up icon 3.37%
$167.01
price down icon 0.73%
$78.01
price up icon 1.00%
COO COO
$70.31
price up icon 0.11%
WST WST
$328.20
price down icon 7.67%
RMD RMD
$195.27
price up icon 1.76%
Cap:     |  Volume (24h):